Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
posted on
Nov 02, 2020 01:14PM
fuzzyjr - So far we are only talking about the 6 year extension of RVX's patent. What about the extension of the patent of the SGLT company's patent that we may be partnering with? Is that going to be 20yrs, 7yrs or 3yrs? No matter how you cut it this patent extension increases the commercial value of this combination of an SGLT2i/ABL by many many billions.
Okay I'll take May rose coloured glasses off now.
tada